Align Technology, Inc. (ALGN)

Market Cap	11.33B
Revenue (ttm)	3.98B
Net Income (ttm)	378.40M
Shares Out	71.75M
EPS (ttm)	5.16
PE Ratio	30.58
Forward PE	14.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	407,352
Open	157.30
Previous Close	156.76
Day's Range	156.75 - 158.58
52-Week Range	122.00 - 237.23
Beta	1.86
Analysts	Buy
Price Target	187.50 (+18.79%)
Earnings Date	Feb 4, 2026

About ALGN

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. T...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 20,945
• Stock Exchange: NASDAQ
• Ticker Symbol: ALGN
• Website: https://www.aligntech.com

Financial Performance

In 2024, Align Technology's revenue was $4.00 billion, an increase of 3.54% compared to the previous year's $3.86 billion. Earnings were $421.36 million, a decrease of -5.32%.

Analyst Summary

According to 13 analysts, the average rating for ALGN stock is "Buy." The 12-month stock price target is $187.5, which is an increase of 18.79% from the latest price.

Price Target

$187.5

(18.79% upside)

Analyst Consensus: Buy